Dementia Care Research and Psychosocial Factors

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Dementia encompasses various brain conditions like Alzheimer's, presenting diverse symptoms including mood changes, agitation, and sleep disturbances.
• Neuropsychiatric symptoms of dementia are a growing concern, prompting interest in cannabis-derived medicines.
• Existing research explores the potential of cannabinoids for symptomatic relief in dementia patients.

Purpose of the Study:

• To examine attitudes towards using cannabinoids for symptomatic treatment of dementia among Australian adults.
• To assess the interest of dementia patients, their caregivers, and healthy controls in participating in medicinal cannabis clinical trials.
• To understand perceptions of benefits and risks associated with cannabis use for dementia.

Main Methods:

• An online questionnaire was administered to dementia patients, study partners (caregivers), and healthy controls from the FRONTIER research database at the University of Sydney.
• The survey assessed attitudes toward medicinal cannabis, perceived benefits and risks, prior cannabis use experience, and willingness to join a hypothetical clinical trial.
• A total of 77 respondents completed the questionnaire: 22 with dementia, 30 study partners, and 25 healthy controls.

Main Results:

• 73% of dementia patients surveyed expressed willingness to participate in a clinical trial for medicinal cannabis.
• 80% of all participants indicated interest in joining a hypothetical clinical trial exploring cannabis for dementia symptom treatment.
• Despite only 24% reporting previous cannabis use, a significant general interest exists in exploring cannabinoid benefits via clinical trials.

Conclusions:

• A strong interest exists among Australian dementia patients and caregivers for participating in clinical trials on medicinal cannabis effectiveness.
• These findings, consistent with other studies, suggest increasing acceptance of cannabis-derived products as potential medical treatments.
• Well-designed clinical trials are crucial to expand symptomatic treatment options for individuals living with dementia.